IDENTIFYNG VALUE –BASED ORGANIZATIONS

Owing to the day-by-day development of technology, global communication, and information networks, the dynamicity of investment and work forces has increased and the organizations such as join stock companies have no choice but to a new organizing era. Value-based organizations are one of the newest forms of today's organizations in which customers are as affecting the production and providing services, working and process strategies, and developing knowledge and competitive power, alongside with the members. "The organizations are always looking for the new methods and creating innovation, and they even name the value of the customer as their 'future source of competitive advantage'" (Kandampully & Khahn, 2004, p.398). Management based on value and value-based organizations are now affecting today's organizations, and values are regarded to be an undeniable source of competitive advantage. Hence, effectively managing the relationship with the customer, and creating and presenting values are the main mission of such organizations. This paper is attempting to provide a definition for the concept of value, and discuss the nature, their features and aspects, the importance, the advantages, key factors in their success, the phases of creating a value-based organization, expanding the values, the future of such organizations, their challenges, and also the role of the leaders in institutionalizing the valuesValue, Value-based Organizations, Value-based Management

Quinoa in Egypt - plant density effects on seed yield and nutritional quality in marginal regions

Grain quinoa is a halophyte crop with potentially increasing cultivation area. Yet, no standards exist for optimum plant density in arid-regions. The aim of this work was to evaluate the effect of planting density on Peruvian valley type of Chenopodium quinoa Willd. cv. CICA from the standpoint of yield and seed quality in marginal area. Two Field experiments were conducted over two consecutive seasons viz., 2015-2016 in a marginal land at El-Fayoum oasis, Egypt with one quinoa cultivar and two planting densities namely, 56.000 plant ha-1(Low) and 167.000 plant ha(High). A complete randomized block design with six replicates was used. Seed yield increased by 34.7% with increase of plant density from 56.000 plant ha-1 to 167.000 plant ha-1. The increase of plant density significantly decreased weight of 1000-seeds and weight of hectoliter. Protein and ash concentrations in seeds increased at low planting density, whereas carbohydrate concentration decreased. However, there were no significant differences between the two planting densities on the seed concentration of the crude fiber or total fat. Regarding effects of plant density on mineral content in quinoa seeds, the calcium and magnesium contents significantly increased at low density compared with high planting density. Meanwhile, no significant effects of plant density on phosphorus, potassium, iron and zinc content in quinoa seeds were detected. Thus, the present study concludes that the plant density that gives higher seed yield is associated with significant reduction in seed quality in terms of protein content. On the other hand, low plant density significantly increased weight of 1000-seeds and hectoliter, which is reflected on the grain size. The latter is considered as a very important parameter for quinoa global market preference.Fil: Eisa, Sayed S.. Faculty Of Agriculture, Ain Shams University, Cairo; EgiptoFil: Abd El Samad, Emad H.. National Research Centre, Egypt; EgiptoFil: Hussin, Sayed A.. Faculty Of Agriculture, Ain Shams University, Cairo; EgiptoFil: Ali, Essam A.. Desert Research Center, Egypt; EgiptoFil: Ebrahim, Mohamed. Faculty Of Agriculture, Ain Shams University, Cairo; EgiptoFil: González, Juan Antonio. Fundación Miguel Lillo; ArgentinaFil: Ordano, Mariano Andrés. Fundación Miguel Lillo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico - Tucumán. Unidad Ejecutora Lillo; ArgentinaFil: Erazzú, Luis Ernesto. Instituto Nacional de Tecnología Agropecuaria; ArgentinaFil: El Bordeny, Nasr E.. Faculty Of Agriculture, Ain Shams University, Cairo; EgiptoFil: Abdel-Ati, Ahmed A.. Desert Research Center, Egypt; Egipt

Status of biosecurity and prevalent parasitic diseases in finfish hatcheries of Jessore, Bangladesh

The present study was conducted to know the status of biosecurity and prevalent parasitic diseases in finfish hatcheries of Jessore district. The peak season of seed production was found April to May. Management of biosecurity has been practiced to prevent disease outbreaks and exert quite satisfactory. It was observed; hatchery owners cleaned their hatchery units regularly and maintained hygiene (76.66%), water quality (56.66%), disinfected equipments (76.00%), stocked disease free broods (76.00%) and quarantine (56.66%). Prevalence of diseases were- lernaeasis (34.10%), argulosis (23.86%), leeches (11.36%), dactylogyrosis (7.95%), gyrodactylosis (10.23%) and others (12.50%) in brood fish and fry. In broods, average prevalence was 16.67% with 9.25% mortality. Besides average prevalence was 10-15% with 10% mortality in fry. The epizootiological pattern showed the highest frequency of parasitic diseases during winter because of loss of appetites. The study demonstrated that sumithion was used by (93.32%), magic (46.33%), depterax (56.67%), lime with KMnO4 (80.00%), lime with salt (66.67%) and lime- salt- KMnO4 (50.00%) by hatchery owners respectively for treatments. Lack of assistance, proper knowledge and suitable therapeutics with its proper use were the major problems in the hatcheries

Biomedical and photocatalytic applications of biosynthesized silver nanoparticles: Ecotoxicology study of brilliant green dye and its mechanistic degradation pathways

© 2020 Elsevier B.V. The preparation of nanoparticles from biological materials is an economic and environmentally friendly strategy with several advantages. The current study is focused to synthesize silver nanoparticles using Petroselinum crispum plant extract. Various characteristics of biologically synthesized AgNPs were determined with UV–Visible (UV/Vis) Spectroscopy, X-ray Diffraction (XRD), Fourier Transform Infrared (FTIR) Spectroscopy, and High-Resolution Transmission Electron Microscopy (HRTEM). The plasmonic resonance peak at 425 nm ensured the formation of AgNPs. The FTIR analysis showed that the as-synthesized particles contain alcoholic and polyphenolic constituents, which are responsible for their capping and reduction. The HRTEM results revealed spherical shape of AgNPs with size ranging from 25 to 90 nm. The as-synthesized particles demonstrated excellent antibacterial properties against Gram positive and Gram-negative bacteria. The antioxidant applications of the particles were determined with 2,2-diphenyle-1-picrylhydrazyl (DPPH). Moreover, the photocatalytic application of the synthesized AgNPs was evaluated for brilliant green dye (BG). The results demonstrated high degradation of BG due to small size and well-dispersed nature of AgNPs. Degradation products of BG were identified to suggest degradation pathways. The eco-toxicity of the BG and constituents derived from the dye were studied with Ecological Structure Activity Relationship (ECOSAR) software

Mapping 123 million neonatal, infant and child deaths between 2000 and 2017

Since 2000, many countries have achieved considerable success in improving child survival, but localized progress remains unclear. To inform efforts towards United Nations Sustainable Development Goal 3.2—to end preventable child deaths by 2030—we need consistently estimated data at the subnational level regarding child mortality rates and trends. Here we quantified, for the period 2000–2017, the subnational variation in mortality rates and number of deaths of neonates, infants and children under 5 years of age within 99 low- and middle-income countries using a geostatistical survival model. We estimated that 32% of children under 5 in these countries lived in districts that had attained rates of 25 or fewer child deaths per 1,000 live births by 2017, and that 58% of child deaths between 2000 and 2017 in these countries could have been averted in the absence of geographical inequality. This study enables the identification of high-mortality clusters, patterns of progress and geographical inequalities to inform appropriate investments and implementations that will help to improve the health of all populations

Mapping child growth failure across low- and middle-income countries

Child growth failure (CGF), manifested as stunting, wasting, and underweight, is associated with high 5 mortality and increased risks of cognitive, physical, and metabolic impairments. Children in low- and middle-income countries (LMICs) face the highest levels of CGF globally. Here we illustrate national and subnational variation of under-5 CGF indicators across LMICs, providing 2000–2017 annual estimates mapped at a high spatial resolution and aggregated to policy-relevant administrative units and national levels. Despite remarkable declines over the study period, many LMICs remain far from the World Health 10 Organization’s ambitious Global Nutrition Targets to reduce stunting by 40% and wasting to less than 5% by 2025. Large disparities in prevalence and rates of progress exist across regions, countries, and within countries; our maps identify areas where high prevalence persists even within nations otherwise succeeding in reducing overall CGF prevalence. By highlighting where subnational disparities exist and the highest-need populations reside, these geospatial estimates can support policy-makers in planning locally 15 tailored interventions and efficient directing of resources to accelerate progress in reducing CGF and its health implications

Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019

Background: The sustainable development goals (SDGs) aim to end HIV/AIDS as a public health threat by 2030. Understanding the current state of the HIV epidemic and its change over time is essential to this effort. This study assesses the current sex-specific HIV burden in 204 countries and territories and measures progress in the control of the epidemic. Methods: To estimate age-specific and sex-specific trends in 48 of 204 countries, we extended the Estimation and Projection Package Age-Sex Model to also implement the spectrum paediatric model. We used this model in cases where age and sex specific HIV-seroprevalence surveys and antenatal care-clinic sentinel surveillance data were available. For the remaining 156 of 204 locations, we developed a cohort-incidence bias adjustment to derive incidence as a function of cause-of-death data from vital registration systems. The incidence was input to a custom Spectrum model. To assess progress, we measured the percentage change in incident cases and deaths between 2010 and 2019 (threshold >75% decline), the ratio of incident cases to number of people living with HIV (incidence-to-prevalence ratio threshold <0·03), and the ratio of incident cases to deaths (incidence-to-mortality ratio threshold <1·0). Findings: In 2019, there were 36·8 million (95% uncertainty interval [UI] 35·1–38·9) people living with HIV worldwide. There were 0·84 males (95% UI 0·78–0·91) per female living with HIV in 2019, 0·99 male infections (0·91–1·10) for every female infection, and 1·02 male deaths (0·95–1·10) per female death. Global progress in incident cases and deaths between 2010 and 2019 was driven by sub-Saharan Africa (with a 28·52% decrease in incident cases, 95% UI 19·58–35·43, and a 39·66% decrease in deaths, 36·49–42·36). Elsewhere, the incidence remained stable or increased, whereas deaths generally decreased. In 2019, the global incidence-to-prevalence ratio was 0·05 (95% UI 0·05–0·06) and the global incidence-to-mortality ratio was 1·94 (1·76–2·12). No regions met suggested thresholds for progress. Interpretation: Sub-Saharan Africa had both the highest HIV burden and the greatest progress between 1990 and 2019. The number of incident cases and deaths in males and females approached parity in 2019, although there remained more females with HIV than males with HIV. Globally, the HIV epidemic is far from the UNAIDS benchmarks on progress metrics. Funding: The Bill & Melinda Gates Foundation, the National Institute of Mental Health of the US National Institutes of Health (NIH), and the National Institute on Aging of the NIH

Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000-17

Background: Universal access to safe drinking water and sanitation facilities is an essential human right, recognised in the Sustainable Development Goals as crucial for preventing disease and improving human wellbeing. Comprehensive, high-resolution estimates are important to inform progress towards achieving this goal. We aimed to produce high-resolution geospatial estimates of access to drinking water and sanitation facilities. Methods: We used a Bayesian geostatistical model and data from 600 sources across more than 88 low-income and middle-income countries (LMICs) to estimate access to drinking water and sanitation facilities on continuous continent-wide surfaces from 2000 to 2017, and aggregated results to policy-relevant administrative units. We estimated mutually exclusive and collectively exhaustive subcategories of facilities for drinking water (piped water on or off premises, other improved facilities, unimproved, and surface water) and sanitation facilities (septic or sewer sanitation, other improved, unimproved, and open defecation) with use of ordinal regression. We also estimated the number of diarrhoeal deaths in children younger than 5 years attributed to unsafe facilities and estimated deaths that were averted by increased access to safe facilities in 2017, and analysed geographical inequality in access within LMICs. Findings: Across LMICs, access to both piped water and improved water overall increased between 2000 and 2017, with progress varying spatially. For piped water, the safest water facility type, access increased from 40·0% (95% uncertainty interval [UI] 39·4–40·7) to 50·3% (50·0–50·5), but was lowest in sub-Saharan Africa, where access to piped water was mostly concentrated in urban centres. Access to both sewer or septic sanitation and improved sanitation overall also increased across all LMICs during the study period. For sewer or septic sanitation, access was 46·3% (95% UI 46·1–46·5) in 2017, compared with 28·7% (28·5–29·0) in 2000. Although some units improved access to the safest drinking water or sanitation facilities since 2000, a large absolute number of people continued to not have access in several units with high access to such facilities (>80%) in 2017. More than 253 000 people did not have access to sewer or septic sanitation facilities in the city of Harare, Zimbabwe, despite 88·6% (95% UI 87·2–89·7) access overall. Many units were able to transition from the least safe facilities in 2000 to safe facilities by 2017; for units in which populations primarily practised open defecation in 2000, 686 (95% UI 664–711) of the 1830 (1797–1863) units transitioned to the use of improved sanitation. Geographical disparities in access to improved water across units decreased in 76·1% (95% UI 71·6–80·7) of countries from 2000 to 2017, and in 53·9% (50·6–59·6) of countries for access to improved sanitation, but remained evident subnationally in most countries in 2017. Interpretation: Our estimates, combined with geospatial trends in diarrhoeal burden, identify where efforts to increase access to safe drinking water and sanitation facilities are most needed. By highlighting areas with successful approaches or in need of targeted interventions, our estimates can enable precision public health to effectively progress towards universal access to safe water and sanitation

Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemic

Introduction Childhood cancer is a leading cause of death. It is unclear whether the COVID-19 pandemic has impacted childhood cancer mortality. In this study, we aimed to establish all-cause mortality rates for childhood cancers during the COVID-19 pandemic and determine the factors associated with mortality. Methods Prospective cohort study in 109 institutions in 41 countries. Inclusion criteria: children &lt;18 years who were newly diagnosed with or undergoing active treatment for acute lymphoblastic leukaemia, non-Hodgkin's lymphoma, Hodgkin lymphoma, retinoblastoma, Wilms tumour, glioma, osteosarcoma, Ewing sarcoma, rhabdomyosarcoma, medulloblastoma and neuroblastoma. Of 2327 cases, 2118 patients were included in the study. The primary outcome measure was all-cause mortality at 30 days, 90 days and 12 months. Results All-cause mortality was 3.4% (n=71/2084) at 30-day follow-up, 5.7% (n=113/1969) at 90-day follow-up and 13.0% (n=206/1581) at 12-month follow-up. The median time from diagnosis to multidisciplinary team (MDT) plan was longest in low-income countries (7 days, IQR 3-11). Multivariable analysis revealed several factors associated with 12-month mortality, including low-income (OR 6.99 (95% CI 2.49 to 19.68); p&lt;0.001), lower middle income (OR 3.32 (95% CI 1.96 to 5.61); p&lt;0.001) and upper middle income (OR 3.49 (95% CI 2.02 to 6.03); p&lt;0.001) country status and chemotherapy (OR 0.55 (95% CI 0.36 to 0.86); p=0.008) and immunotherapy (OR 0.27 (95% CI 0.08 to 0.91); p=0.035) within 30 days from MDT plan. Multivariable analysis revealed laboratory-confirmed SARS-CoV-2 infection (OR 5.33 (95% CI 1.19 to 23.84); p=0.029) was associated with 30-day mortality. Conclusions Children with cancer are more likely to die within 30 days if infected with SARS-CoV-2. However, timely treatment reduced odds of death. This report provides crucial information to balance the benefits of providing anticancer therapy against the risks of SARS-CoV-2 infection in children with cancer